Poly(ADP-ribosyl)ation regulation of life and death in the nervous system

Cellular and Molecular Life Sciences

Volumn 62, Issue 7-8, 2005, Pages 760-768

  Koh, D W ^a   Dawson, T M ^a   Dawson, V L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Apoptosis inducing factor; Cell death; DNA damage; Excitotoxicity; PARG; PARP; Poly(ADP ribose)

Indexed keywords

1,5 DIHYDROXYISOQUINOLINE; APOPTOSIS INDUCING FACTOR; BENZAMIDE; CASPASE; ENZYME INHIBITOR; GLYCOSIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOQUINOLINE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLY(ADENOSINE DIPHOSPHATE RIBOSE)GLYCOHYDROLASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; BRAIN INJURY; BRAIN ISCHEMIA; CELL DAMAGE; CELL DEATH; CELL ENERGY; CELL PROTECTION; CELL SURVIVAL; DEGENERATIVE DISEASE; DISEASE SEVERITY; DNA DAMAGE; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; EUKARYOTE; GENE DISRUPTION; MITOCHONDRION; NERVE CELL; NERVOUS SYSTEM; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPERFUSION INJURY; REVIEW; STRESS; STROKE;

ANIMALS; APOPTOSIS INDUCING FACTOR; CELL DEATH; DNA DAMAGE; FLAVOPROTEINS; HUMANS; MEMBRANE PROTEINS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES;

EUKARYOTA; RICKETTSIA SP. PAR;

EID: 18544382022     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4508-y     Document Type: Review

References (74)

1. Chambon P., Weil J. D. and Mandel P. (1963) Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 11: 39-43
2. Nishizuka Y., Ueda K., Nakazawa K. and Hayaishi O. (1967) Studies on the polymer of adenosine diphosphate ribose. I. Enzymic formation from nicotinamide adenine dinuclotide in mammalian nuclei. J. Biol. Chem. 242 (13): 3164-3171
3. de Murcia G. and Shall S., eds (2000) From DNA Damage and Stress Signaling to Cell Death: Poly ADP-Ribosylation Reactions, Oxford University Press, New York
4. Menissier de Murcia J., Ricoul M., Tartier L., Niedergang C., Huber A., Dantzer F. et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. Embo J. 22 (9): 2255-2263
5. Kickhoefer V. A., Siva A. C., Kedersha N. L., Inman E. M., Ruland C., Streuli M. et al. (1999) The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146 (5): 917-928
6. Smith S., Giriat I., Schmitt A. and de Lange T. (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282 (5393): 1484-1487
7. Juarez-Salinas H., Sims J. L. and Jacobson M. K. (1979) Poly(ADP-ribose) levels in carcinogen-treated cells. Nature 282 (5740): 740-741
8. Augustin A., Spenlehauer C., Dumond H., Menissier-De Murcia J., Fiel M., Schmit A. C. et al. (2003) PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J. Cell Sci. 116 (Pt 8): 1551-1562
9. Amé J. C., Rolli V., Schreiber V., Niedergang C., Apiou F., Decker P. et al. (1999) PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem. 274 (25): 17860-17868
10. Miwa M., Saikawa N., Yamaizumi Z., Nishimura S. and Sugimura T. (1979) Structure of poly(adenosine diphosphate ribose): identification of 2′- [1-ribosyl-2″-(or 3‴-)(1″-ribosyl)]-adenosine-5′, 5″,5‴-tris(phosphate) as a branch linkage. Proc. Natl. Acad. Sci. USA 76 (2): 595-599
11. Amé J. C., Jacobson E. L. and Jacobson M. K. (2000) ADP-ribose polymer metabolism. In: From DNA Damage and Stress Signaling to Cell Death: Poly-ADP-Ribosylation Reactions, pp. 1-34, de Murcia G. and Shall S. (eds), Oxford University Press, New York
12. Brochu G., Duchaine C., Thibeault L., Lagueux J., Shah G. M. and Poirier G. G. (1994) Mode of action of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta 1219 (2): 342-350
13. Oka J., Ueda K., Hayaishi O., Komura H. and Nakanishi K. (1984) ADP-ribosyl protein lyase. Purification, properties and identification of the product. J. Biol. Chem. 259 (2): 986-995
14. D'Amours D., Desnoyers S., D'Silva I. and Poirier G. G. (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342 (Pt 2): 249-268
15. Dantzer F., de La Rubia G., Menissier-De Murcia J., Hostomsky Z., de Murcia G. and Schreiber V. (2000) Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. Biochemistry 39 (25): 7559-7569
16. Shall S. and de Murcia G. (2000) Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat. Res. 460 (1): 1-15
17. Hassa P. O. and Hottiger M. O. (1999) A role of poly (ADP-ribose) polymerase in NF-kappaB transcriptional activation. Biol. Chem. 380 (7-8): 953-959
18. Yu S. W., Wang H., Dawson T. M. and Dawson V. L. (2003) Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis. 14 (3): 303-317
19. Southan G. J. and Szabo C. (2003) Poly(ADP-ribose) polymerase inhibitors. Curr. Med. Chem. 10 (4): 321-340
20. Szabo C. and Dawson V. L. (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 (7): 287-298
21. Jacobson M. K. and Jacobson E. L. (1999) Discovering new ADP-ribose polymer cycles: protecting the genome and more. Trends Biochem. Sci. 24 (11): 415-417
22. Canan Koch S. S., Thoresen L. H., Tikhe J. G., Maegley K. A., Almassy R. J., Li J. et al. (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis and X-ray cocrystal structure. J. Med. Chem. 45 (23): 4961-4974
23. Zhang J., Dawson V. L., Dawson T. M. and Snyder S. H. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263 (5147): 687-689
24. Ullrich O., Diestel A., Eyupoglu I. Y. and Nitsch R. (2001) Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell. Biol. 3 (12): 1035-1042
25. Lautier D., Lagueux J., Thibodeau J., Ménard L. and Poirier G. G. (1993) Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol. Cell. Biochem. 122 (2): 171-193
26. Adamietz P. (1987) Poly(ADP-ribose) synthase is the major endogenous nonhistone acceptor for poly(ADP-ribose) in alkylated rat hepatoma cells. Eur. J. Biochem. 169 (2): 365-372
27. Adamietz P. and Rudolph A. (1984) ADP-ribosylation of nuclear proteins in vivo. Identification of histone H2B as a major acceptor for mono- and poly(ADP-ribose) in dimethyl sulfate-treated hepatoma AH 7974 cells. J. Biol. Chem. 259 (11): 6841-6846
28. Ruscetti T., Lehnert B. E., Halbrook J., Le Trong H., Hoekstra M. F., Chen D. J. et al. (1998) Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase. J. Biol. Chem. 273 (23): 14461-14467
29. Wesierska-Gadek J., Schmid G. and Cerni C. (1996) ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem. Biophys. Res. Commun. 224 (1): 96-102
30. Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G. and Earnshaw W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 (6495): 346-347
31. D'Amours D., Sallmann F. R., Dixit V. M. and Poirier G. G. (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J. Cell Sci. 114 (Pt 20): 3771-3778
32. Berger N. A. (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101 (1): 4-15
33. Eliasson M. J., Sampei K., Mandir A. S., Hurn P. D., Traystman R. J., Bao J. et al. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3 (10): 1089-1095
34. Sampei K., Mandir A. S., Asano Y., Wong P. C., Traystman R. J., Dawson V. E. et al. (2000) Stroke outcome in double-mutant antioxidant transgenic mice. Stroke 31 (11): 2685-2691
35. Baeuerle P. A. and Baltimore D. (1996) NF-kappa B: ten years after. Cell 87 (1): 13-20
36. Piret B., Schoonbroodt S. and Piette J. (1999) The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene 18 (13): 2261-2271
37. Oliver F. J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S. et al. (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18 (16): 4446-4454
38. Chiarugi A. and Moskowitz M. A. (2003) Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem. 85 (2): 306-17
39. Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407 (6805): 770-776
40. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (6718): 441-446
41. Joza N., Susin S. A., Daugas E., Stanford W. L., Cho S. K., Li C. Y. et al. (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410 (6828): 549-554
42. Lorenzo H. K., Susin S. A., Penninger J. and Kroemer G. (1999) Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6 (6): 516-524
43. Mate M. J., Ortiz-Lombardia M., Boitel B., Haouz A., Tello D., Susin S. A. et al. (2002) The crystal structure of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol. 9 (6): 442-446
44. Yu S. W., Wang H., Poitras M. F., Coombs C., Bowers W. J., Federoff H. J. et al. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (5579): 259-263
45. Lin W., Ame J. C., Aboul-Ela N., Jacobson E. L. and Jacobson M. K. (1997) Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 272 (18): 11895-11901
46. Shimokawa T., Masutani M., Nagasawa S., Nozaki T., Ikota N., Aoki Y. et al. (1999) Isolation and cloning of rat poly(ADP-ribose) glycohydrolase: presence of a potential nuclear export signal conserved in mammalian orthologs. J. Biochem. (Tokyo) 126 (4): 748-755
47. Koh D. W., Patel C. N., Ramsinghani S., Slama J. T., Oliveira M. A. and Jacobson M. K. (2003) Identification of an inhibitor binding site of poly(ADP-ribose) glycohydrolase. Biochemistry 42 (17): 4855-4863
48. Koh D. W., Coyle D. L., Mehta N., Ramsinghani S., Kim H., Slama J. T. et al. (2003) SAR analysis of adenosine diphosphate (hydroxymethyl)pyrrolidinediol inhibition of poly(ADP-ribose) glycohydrolase. J. Med. Chem. 46 (20): 4322-4332
49. Ying W., Sevigny M. B., Chen Y. and Swanson R. A. (2001) Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. USA 98 (21): 12227-12232
50. Lu X. C., Massuda E., Lin Q., Li W., Li J. H. and Zhang J. (2003) Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 978 (1-2): 99-103
51. Hanai S., Kanai M., Ohashi S., Okamoto K., Yamada M., Takahashi H. et al. (2003) Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 101: 82-86
52. Panda S., Poirier G. G. and Kay S. A. (2002) tej defines a role for Poly(ADP-ribosyl)ation in establishing period length of the Arabidopsis circadian oscillator. Dev. Cell 3 (1): 51-61
53. Lang A. E. and Lozano A. M. (1998) Parkinson's disease. Second of two parts. N. Engl. J. Med. 339 (16): 1130-1143
54. Lang A. E. and Lozano A. M. (1998) Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (15): 1044-1053
55. Dawson T. M. (2000) New animal models for Parkinson's disease. Cell 101 (2): 115-118
56. Lee C. S., Schulzer M., Mak E. K., Snow B. J., Tsui J. K., Calne S. et al. (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117 (Pt 3): 501-507
57. Dawson T. M. and Dawson V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (5646): 819-822
58. Schapira A. H. (1996) Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Adv. Neurol. 69: 161-165
59. Mizuno Y., Sone N. and Saitoh T. (1987) Effects of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J. Neurochem. 48 (6): 1787-1793
60. Forno L. S., Langston J. W., DeLanney L. E., Irwin I. and Ricaurte G. A. (1986) Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann. Neurol. 20 (4): 449-55
61. Dawson V. L. and Dawson T. M. (1996) Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10 (3-4): 179-190
62. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349 (6308): 414-418
63. Cosi C., Suzuki H., Skaper S. D., Milani D., Facci L., Menegazzi M. et al. (1997) Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents. Ann. N. Y. Acad. Sci. 825: 366-379
64. Mandir A. S., Przedborski S., Jackson-Lewis V., Wang Z. Q., Simbulan-Rosenthal C. M., Smulson M. E. et al. (1999) Poly-(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. USA 96 (10): 5774-5779
65. Wang H., Shimoji M., Yu S. W., Dawson T. M. and Dawson V. L. (2003) Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease. Ann. N. Y. Acad. Sci. 991: 132-139
66. McIntosh T. K., Juhler M. and Wieloch T. (1998) Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. J. Neurotrauma 15 (10): 731-769
67. Zhang X., Chen J., Graham S. H., Du L., Kochanek P. M., Draviam R. et al. (2002) Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82 (1): 181-191
68. Hooper D. C., Scott G. S., Zborek A., Mikheeva T., Kean R. B., Koprowski H. et al. (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14 (5): 691-698
69. Scott G. S., Kean R. B., Mikheeva T., Fabis M. J., Mabley J. G., Szabo C. et al. (2004) The therapeutic effects of PJ34, a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J. Pharmacol. Exp. Ther. 310: 1053-1061
70. Virag L. and Szabo C. (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54 (3): 375-429
71. Stoll G., Jander S. and Schroeter M. (1998) Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56 (2): 149-171
72. Mabuchi T., Kitagawa K., Ohtsuki T., Kuwabara K., Yagita Y., Yanagihara T. et al. (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31 (7): 1735-1743
73. Koedel U., Winkler F., Angele B., Fontana A. and Pfister H. W. (2002) Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 22 (1): 39-49
74. Braun J. S., Novak R., Murray P. J., Eischen C. M., Susin S. A., Kroemer G. et al. (2001) Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J. Infect. Dis. 184 (10): 1300-1309